Content

ClinTec Expands to Middle East, North Africa

Allison Proffitt — Tue, 21 May 2013 17:00:47 GMT

Business Insider | CRO firm ClinTec International has opened an office in Istanbul. Now operating in 40 countries, ClinTec's Turkey office will further consolidate its presence in the Middle East and North Africa.

Singapore Launches New Flu Vaccine Trial

Allison Proffitt — Mon, 20 May 2013 16:53:23 GMT

MedicalXpress | Singapore's A*STAR and Swiss group Cytos Biotechnology have launched a Phase 1 clinical trial for an H1N1 flu vaccine, making use of Cytos’ virus-like particle (VLP) technology.

Building Enthusiasm for Clinical Trials

Allison Proffitt — Mon, 20 May 2013 16:40:47 GMT

PhysBizTech | Using a trial search engine and educational web videos, researchers at the Seidman Cancer Center at Case Western Reserve University School of Medicine have been looking into ways to help build enthusiasm for clinical trials from both patients and practitioners.

Convergence and Big Data: Conversations from the Post-Approval Summit

Allison Proffitt — Mon, 20 May 2013 15:53:56 GMT

Clinical Informatics News | Dr. Richard Gliklich, President of the Quintiles Outcome Division of Quintiles, gave Clinical Informatics News a summary of conversations and issues raised at the 2013 Post-Approval Summit.

MIT Develops Insulin-Releasing Nanoparticles

Allison Proffitt — Thu, 16 May 2013 17:51:50 GMT

Diabetes News | Massachusetts Institute of Technology (MIT) researchers recently developed injectable nanoparticles for patients with type 1 diabetes. These nanoparticles are designed to replace the function of islet cells.

Generics Fraud: An Investigation

Allison Proffitt — Wed, 15 May 2013 16:13:35 GMT

CNN Money | Excellent reporting into the long-term criminal fraud at Ranbaxy—the Indian drug company that makes generic Lipitor.

Certara, Veristat Form Alliance to Streamline Discovery, Trial Process

Allison Proffitt — Thu, 16 May 2013 14:22:31 GMT

eCliniqua | Certara and Veristat have formed an alliance to offer pharmacokinetic (PK) analysis, PK /pharmacodynamic (PD) modeling, population PK modeling, trial simulation, clinical biostatistics, medical writing, data management, clinical monitoring, safety management, and project management to their clients.

Instem Acquires Logos Technologies, Plans SaaS Offering

Allison Proffitt — Tue, 14 May 2013 18:50:00 GMT

eCliniqua News Brief | Instem has acquired Logos Technologies, representing its strategic move into the early phase clinical trials market. Logos’ ALPHADAS software solution suite is a proactive eSource clinical trials system that is mobile, schedule-driven, and provides real-time bedside or station based direct data capture.

Bacteria Detection Device Could ID Pathogens at Bedside

Allison Proffitt — Tue, 14 May 2013 18:36:50 GMT

Forbes | Using DNA hybridization and detection with a miniaturized nuclear magnetic resonance (NMR) device about the size of a microscope slide, researchers are able to test for several bacterial pathogens at once within hours.

Breast Cancer Trials Test Several Therapies at Once

Allison Proffitt — Tue, 14 May 2013 18:31:08 GMT

OncLive | The I-SPY trials for breast cancer are aiming to test several experimental therapies at once to determine which ones work best in which patients.

Moffitt Uses Biosamples to Improve Trial Efficiency

Allison Proffitt — Mon, 13 May 2013 16:20:53 GMT

News Medical | According to researchers at Total Care Cancer (a comprehensive approach to cancer launched at Moffitt Cancer Center), using biosamples for phase II cancer trials improves research efficiency, cost, and the rate of drug development.

Merge EDC Solution Deployed by South African CRO

Allison Proffitt — Fri, 10 May 2013 20:06:05 GMT

PBR | OnQ Research, a South Africa-based Clinical Research Organization, has selected Merge's eClinical OS solution for electronic data capture to expand their in-house data management service offering.

Quintiles' IPO Raises $947m

Allison Proffitt — Fri, 10 May 2013 13:47:16 GMT

Med City News | Quintiles' second IPO yesterday raised $947 million. The offering prices Quintiles at $6.6 billon, 70% larger than the next largest CRO--Covance.

PRO-ACT: Bigger and Better ALS Database Open for Mining

Allison Proffitt — Fri, 10 May 2013 13:12:02 GMT

eCliniqua | Amyotrophic lateral sclerosis (ALS) research is getting a major boost from a newly launched Pooled Resource Open-access ALS Clinical Trials (PRO-ACT) platform, which has amassed more than 8,500 de-identified clinical patient records into a single, harmonized dataset. Multiple pharmaceutical companies are now actively exploring PRO-ACT, seeking ways to streamline clinical trials and develop better treatments for the rare and highly heterogeneous disease more commonly known as Lou Gehrig’s disease.

Genomic Prostate Cancer Test Gauges Tumor Aggressiveness

Allison Proffitt — Thu, 09 May 2013 12:25:24 GMT

Boston Herald | A new genetic test—Oncotype DX Genomic Prostate Score—purports to gauge the aggressiveness of prostate cancer, helping doctors and patients decide if they should their cancer right away or can safely monitor it.